Establishes a precision oncology program for prostate cancer at the Department of Veterans Affairs.
The Precision Oncology Program for Cancer of the Prostate Authorization Act of 2026 mandates the establishment of a precision oncology program for prostate cancer within the Department of Veterans Affairs. The program will be overseen by a Program Leadership team based at the Seattle VA Medical Center. The bill designates specific medical facilities as Centers of Excellence, requiring them to conduct genetic sequencing for veterans with advanced prostate cancer and participate in the Telemedicine Tumor Board.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.